TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10224212

Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution) before feeding
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intraoral water before feeding
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution) after feeding
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intraoral water after feeding
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intraoral water
Number of subjects: 38
Study: 8914780

Group type: EXPERIMENTAL
Intervention: Integrelin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 1877037

Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms twice daily) and terbutaline (500 micrograms four times daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Terbutaline alone (placebo)
Number of subjects: 27
Study: 7088766

Group type: EXPERIMENTAL
Intervention: 0.25 mg ergotamine by injection (6 i.v. and 11 i.m.)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 2 mg ergotamine by mouth
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 2 mg ergotamine by suppository
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Plasma ergotamine levels exceeding 1.8 ng/ml
Number of subjects: 41
Study: 31172717

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS) via transnasal nebulization
Number of subjects: 91

Group type: COMPARATOR
Intervention: Budesonide nasal spray (BNS)
Number of subjects: 91
Study: 28295174

Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 245

Group type: COMPARATOR
Intervention: Repeat PGE2
Number of subjects: 245
Study: 26697823

Group type: EXPERIMENTAL
Intervention: 2 meals a day (B2)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 6 meals a day (A6)
Number of subjects: 54
Study: 24282036

Group type: EXPERIMENTAL
Intervention: Fasting Plasma Glucose (FPG)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Two-step 50 g Glucose Challenge Test (GCT)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: 75 g Glucose Tolerance Test (GTT)
Number of subjects: 486
Study: 22002075

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 24

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 24
Study: 18976320

Group type: EXPERIMENTAL
Intervention: Antiepileptic drug (AED) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine (subgroup of AED monotherapy)
Number of subjects: 0
Study: 17590500

Group type: EXPERIMENTAL
Intervention: Acute exercise (treadmill walking for 45 min at 50% of VO(2)peak)
Number of subjects: 9
Study: 15200583

Group type: EXPERIMENTAL
Intervention: Regular amphetamine use
Number of subjects: 214
Study: 11679498

Group type: EXPERIMENTAL
Intervention: Recombinant FSH
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urinary FSH
Number of subjects: 0
Study: 10023367

Group type: EXPERIMENTAL
Intervention: Educational intervention on STD recognition, management, and prevention counselling
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 180
Study: 8167489

Group type: EXPERIMENTAL
Intervention: ABP machine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: TM2420 machine
Number of subjects: 6
Study: 3071266

Group type: EXPERIMENTAL
Intervention: Clindamycin (3 x 600 mg in 100 ml 0.9% saline)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metronidazole (3 x 500 mg in 100 ml 0.9% saline)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (3 x 100 ml of 0.9% saline)
Number of subjects: 120
Study: 31658115

Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Crystalloid (PlasmaLyte)
Number of subjects: 59
Study: 30832678

Group type: EXPERIMENTAL
Intervention: Enhanced feedback
Number of subjects: 2299

Group type: COMPARATOR
Intervention: Standard feedback
Number of subjects: 2299
Study: 27802112

Group type: EXPERIMENTAL
Intervention: Access2Aphasia™ (online-led assessment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Face-to-face (FTF) assessment
Number of subjects: 30
Study: 26511799

Group type: EXPERIMENTAL
Intervention: Care as usual plus SOS training (N = 125)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Care as usual only (N = 125)
Number of subjects: 250
Study: 23015618

Group type: EXPERIMENTAL
Intervention: Computer-controlled infusion of phenylephrine (100 µg ml(‐1))
Number of subjects: 222

Group type: COMPARATOR
Intervention: Manual-controlled infusion of phenylephrine
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Computer-controlled infusion of phenylephrine
Number of subjects: 222
Study: 21518565

Group type: EXPERIMENTAL
Intervention: Coated VICRYL Plus antibacterial (Polyglactin 910) suture
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chinese silk suture
Number of subjects: 101
Study: 19328368

Group type: EXPERIMENTAL
Intervention: Sunmed GEB
Number of subjects: 34

Group type: COMPARATOR
Intervention: Portex GEB
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Greenfield GEB
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Eschmann GEB
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: EM physicians
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anesthesiologists
Number of subjects: 34
Study: 17018329

Group type: EXPERIMENTAL
Intervention: BoNTA (7.5 U, 25 U, or 50 U)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: BoNTA (25 U or 50 U)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Continuation of BoNTA (25 U or 50 U)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 12833013

Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% foam plus vehicle spray
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% foam plus 0.25% zinc pyrithione spray
Number of subjects: 25
Study: 10827212

Group type: EXPERIMENTAL
Intervention: 20 g/d FOS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 10
Study: 8895624

Group type: EXPERIMENTAL
Intervention: Continuous passive motion machine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Drop and dangle protocol
Number of subjects: 83
Study: 1520648

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg bid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (20-40 mg bid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Atenolol and Nifedipine
Number of subjects: 0
Study: 6238190

Group type: EXPERIMENTAL
Intervention: Schizophyllan (SPG)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study: 30773564

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block (group I) with 0.2% ropivacaine 10 mL
Number of subjects: 40

Group type: COMPARATOR
Intervention: C5‐6 nerve root block (group C) with 0.2% ropivacaine 10 mL
Number of subjects: 40
Study: 30391368

Group type: EXPERIMENTAL
Intervention: EEG classification at 24 hours
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: EEG classification at 48 hours
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: EEG reactivity at 24 hours
Number of subjects: 164
Study: 28583834

Group type: EXPERIMENTAL
Intervention: Structured education intervention in two sessions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group without intervention
Number of subjects: 60
Study: 25479729

Group type: EXPERIMENTAL
Intervention: Training Group (TG) - supervised bilateral short contact hopping training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention
Number of subjects: 20
Study: 23706715

Group type: EXPERIMENTAL
Intervention: 6 Amb a 1 units ragweed AIT
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: 12 Amb a 1 units ragweed AIT
Number of subjects: 565

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study: 21211840

Group type: EXPERIMENTAL
Intervention: Early peripheral retinal ablation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 63
Study: 19372331

Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg followed by an infusion of 2.5 mg x kg(‐1) x h(‐1) for 59 min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Midazolam (C(blood): 225 ng/mL)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mean arterial blood pressure inclusion
Number of subjects: 8
Study: 16894336

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-dose EPT (1 mg 17beta-estradiol + 0.5 mg norethisterone acetate)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments (T and low-dose EPT)
Number of subjects: 40
Study: 15136349

Group type: COMPARATOR
Intervention: Triple-contrast CT scan
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Rectal-contrast CT scan
Number of subjects: 91
Study: 11280073

Group type: EXPERIMENTAL
Intervention: Polonga TAb (1 g)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Haffkine antivenom (10 g)
Number of subjects: 43
Study: 9512850

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) removal when deeply anaesthetised
Number of subjects: 165

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA) removal when awake
Number of subjects: 165
Study: 7817029

Group type: EXPERIMENTAL
Intervention: External argon laser choroidotomy
Number of subjects: 175

Group type: COMPARATOR
Intervention: Needle drainage
Number of subjects: 175
Study: 3377955

Group type: EXPERIMENTAL
Intervention: Preoperative intercostal nerve blocks of the 6th to 12th nerves bilaterally using 0.5% bupivacaine with adrenaline 250 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group with adrenaline infiltrated into the intercostal space
Number of subjects: 20
Study: 29617982

Group type: EXPERIMENTAL
Intervention: 1500 mg single oral dose of gepotidacin
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 3000 mg single oral dose of gepotidacin
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combined dose groups (1500 mg and 3000 mg)
Number of subjects: 69

Group type: COMPARATOR
Intervention: N/A (control not specified)
Number of subjects: 69
Study: 26020712

Group type: EXPERIMENTAL
Intervention: Vortioxetine 15-20 mg
Number of subjects: 1075
Study: 24228504

Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -20 kPa
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -40 kPa
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -60 kPa
Number of subjects: 21
Study: 21464374

Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia to 33.5°C for 72 hours
Number of subjects: 221

Group type: COMPARATOR
Intervention: Standard care (37°C)
Number of subjects: 221
Study: 18026685

Group type: EXPERIMENTAL
Intervention: 70% oxygen
Number of subjects: 100

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 100
Study: 16848340

Group type: EXPERIMENTAL
Intervention: Nurse case management and incentives (NCMI)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Standard care and incentives (Control)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Both programs
Number of subjects: 520
Study: 12764691

Group type: EXPERIMENTAL
Intervention: Thiopental 5‐7 mg/kg IV
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Etomidate 0.2‐0.3 mg/kg IV
Number of subjects: 30
Study: 10838679

Group type: EXPERIMENTAL
Intervention: Brief Eclectic Psychotherapy (BEP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study: 9112508

Group type: EXPERIMENTAL
Intervention: Absorbable stent
Number of subjects: 116

Group type: COMPARATOR
Intervention: No stent
Number of subjects: 116
Study: 1589135

Group type: EXPERIMENTAL
Intervention: L-sulpiride (75 mg die per os)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metoclopramide (30 mg die per os)
Number of subjects: 50
Study: 6112039

Group type: EXPERIMENTAL
Intervention: Pirbuterol (beta agonist with vasodilator and positive inotropic properties)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Single oral dose of pirbuterol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Incremental doses of pirbuterol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Pirbuterol
Number of subjects: 59
Study: 30516414

Group type: EXPERIMENTAL
Intervention: Oscillating-rotating toothbrush
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sonic toothbrush
Number of subjects: 44
Study: 27842315

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2, 0.1, and 0.1 mg/kg i.v. every 24 h for 3 doses)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Ibuprofen lysine (10, 5, and 5 mg/kg i.v. every 24 h for 3 doses)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 144

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 144
Study: 25873151

Group type: EXPERIMENTAL
Intervention: Cycle ergometer and conventional exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional exercises
Number of subjects: 0
Study: 22797979

Group type: EXPERIMENTAL
Intervention: Gadobutrol 1.0 M
Number of subjects: 72

Group type: COMPARATOR
Intervention: Gadobenate dimeglumine 0.5 M
Number of subjects: 72
Study: 21286719

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy concurrent with radiotherapy
Number of subjects: 81
Study: 19038534

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day (immediate initiation with simultaneous discontinuation of olanzapine/risperidone)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day (immediate initiation while tapering off olanzapine/risperidone over 14 days)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day (titrating upwards while tapering off olanzapine/risperidone over 14 days)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day (all groups)
Number of subjects: 269
Study: 17940371

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total mesorectal excision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resection plus postoperative chemoradiotherapy
Number of subjects: 0
Study: 17198261

Group type: EXPERIMENTAL
Intervention: FTY720 2.5 mg plus full-dose cyclosporine (FDC)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) plus full-dose cyclosporine (FDC)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: FTY720 5 mg plus reduced-dose cyclosporine (RDC)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: FTY720 2.5 mg plus FDC
Number of subjects: 696
Study: 12697283

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10) supplementation (360 mg daily for 4 weeks)
Number of subjects: 28
Study: 10521100

Group type: EXPERIMENTAL
Intervention: 3.75 mg i.m. dose of triptorelin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 53
Study: 7595707

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM; 20 mg/d)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Toremifene (TOR; 60 mg/d)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Toremifene (TOR; 200 mg/d)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 648
Study: 2196954

Group type: EXPERIMENTAL
Intervention: Insertion of a grommet (with or without adenoidectomy and myringotomy)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Adenoidectomy with myringotomy and grommet insertion
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 127

Group type: COMPARATOR
Intervention: Myringotomy and grommet insertion (without adenoidectomy)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 127
Study: 6161320

Group type: EXPERIMENTAL
Intervention: (‐)Deprenyl 10 mg daily for 4 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: (‐)Deprenyl
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29792519

Group type: EXPERIMENTAL
Intervention: Online physician reviews endorsing technical skills of a female PCP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online physician reviews endorsing technical skills of a male PCP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online physician reviews endorsing interpersonal skills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online physician reviews endorsing technical skills
Number of subjects: 0
Study: 28202404

Group type: EXPERIMENTAL
Intervention: Single-dose rhC1-INH 50 U/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Single-dose rhC1-INH 2100 U
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Additional doses after initial rhC1-INH 2100 U dose (total dose, 4200-6300 U)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: rhC1-INH
Number of subjects: 16
Study: 26272170

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied on the day of separation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no LLLT)
Number of subjects: 40
Study: 23742176

Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 81
Study: 21525161

Group type: EXPERIMENTAL
Intervention: 17β‐estradiol 0.05 mg/d
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: zolpidem 10 mg/d
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 18594905

Group type: EXPERIMENTAL
Intervention: Metallic stents
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Covered metallic stents
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Uncovered metallic stents
Number of subjects: 1475

Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 1475
Study: 17178983

Group type: EXPERIMENTAL
Intervention: Imiquimod in combination with meglumine antimoniate
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo with meglumine antimoniate
Number of subjects: 119
Study: 14560417

Group type: EXPERIMENTAL
Intervention: Polished surface finish femoral components
Number of subjects: 226

Group type: COMPARATOR
Intervention: Grit-blasted surface finish femoral components
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Polished and grit-blasted components
Number of subjects: 226
Study: 10971314

Group type: EXPERIMENTAL
Intervention: Detergent washed spacer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated new spacer
Number of subjects: 20
Study: 8607331

Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone
Number of subjects: 10
Study: 1727882

Group type: EXPERIMENTAL
Intervention: 1% silver sulfadiazine cream applied twice daily to the urethral meatus
Number of subjects: 696

Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: 1% silver sulfadiazine cream
Number of subjects: 696
Study: 6395321

Group type: EXPERIMENTAL
Intervention: Naproxen (NAP) 10 mg/kg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 75 mg/kg/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naproxen (NAP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 80
Study: 30975228

Group type: EXPERIMENTAL
Intervention: Transgenic Camelina sativa seed oil (CSO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial blended fish oil (BFO)
Number of subjects: 0
Study: 29451953

Group type: EXPERIMENTAL
Intervention: Fluorescence visualization-guided surgical approach
Number of subjects: 248

Group type: COMPARATOR
Intervention: Non-adjacent-fluorescence visualization margins
Number of subjects: 248
Study: 26947697

Group type: EXPERIMENTAL
Intervention: Propylbetaine‐polihexanide (PP) solution (Prontosan)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Normal saline (NS) solution
Number of subjects: 289
Study: 24883449

Group type: EXPERIMENTAL
Intervention: Add-on group (prolonged RF application to 90 seconds)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (standard RF application of 30 seconds)
Number of subjects: 131
Study: 22686133

Group type: EXPERIMENTAL
Intervention: Move It Now, a guided self-help intervention via the Internet using cognitive behavioural techniques
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 60
Study: 21034176

Group type: EXPERIMENTAL
Intervention: Netilmycin/Dexamethasone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tobramycin/Dexamethasone
Number of subjects: 80
Study: 17400980

Group type: EXPERIMENTAL
Intervention: Subgluteus approach with mepivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Popliteal approach with mepivacaine
Number of subjects: 48
Study: 16372487

Group type: EXPERIMENTAL
Intervention: Whole-breast radiotherapy (WBRT) (40 Gy in 15 fractions)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Partial-breast irradiation by a variety of techniques
Number of subjects: 174
Study: 11696205

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.7 mg/kg, t.i.d.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9390413

Group type: EXPERIMENTAL
Intervention: Self-esteem
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Source of the prophecy
Number of subjects: 222
Study: 8198900

Group type: EXPERIMENTAL
Intervention: FIO2 0.60
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Model B with variable two-compartment relative V/Q mismatch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Postoperative PaO2 data from other workers
Number of subjects: 20
Study: 3241272

Group type: EXPERIMENTAL
Intervention: Aerobic (lactate threshold) exercise therapy for 10 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-exercising hypertensive control group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise group responders (10 mmHg or more fall in mean blood pressure)
Number of subjects: 21
Study: 29189426

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity (moderate physical activity during routine daily activities)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (HIV-uninfected adults)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: HIV-positive adults
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Current CD4+ T cell count
Number of subjects: 109
Study: 26331290

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 711